Fairen-Jimenez Lab

University of Cambridge

- · United Kingdom

ERC-funded
Rate this labNo reviews yet — be the first.

Research focus

ERC Consolidator Grant · 2016

Design of NanoMOFs Capsules for Drug Delivery and Bioimaging.

Cancer is a major health problem worldwide, being the most common cause of death after cardiovascular diseases. The major goal of new anticancer therapies is to specifically kill tumour cells while leaving healthy cells unharmed. A main challenge to achieve this aim is the development of better drugs, including novel treatments based on the use of siRNAs. These macromolecules are potentially the most powerful anti-cancer drugs that exist, but still there is no efficient way of getting them delivered specifically to the tumour. Indeed, lifetime of such molecules is generally too short and therefore need to be protected in a carrier until they are delivered into tumour target cells. This…

From the public funding record at EU CORDIS. Describes the funded project, not the reviews below.

Reviews

← All labs at University of Cambridge